Glutathione peroxidase, glutathione reductase, Cu-Zn superoxide dismutase activities, glutathione, nitric oxide, and malondialdehyde concentrations in serum of patients with chronic lymphocytic leukemia

Clinica Chimica Acta

Volumn 338, Issue 1-2, 2003, Pages 143-149

  Bakan, Nuri ^a   Taysi, Seyithan ^a   Yilmaz, Ömer ^a   Bakan, Ebubekir ^a   Kuşkay, Sevinç ^a   Uzun, Naim ^a   Gündoǧdu, Mehmet ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

Glutathione; Glutathione peroxidase; Malondialdehyde; Nitric oxide; Superoxide dismutase

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MALONALDEHYDE; NITRIC OXIDE;

ADULT; AGED; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 0344586157     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.08.013     Document Type: Article

References (58)

1. Cheson B.D. Chronic Lymphoid Leukemias. 1993;33-62 Marcel Dekker, New York.
2. Bennett J.C., Plum F. Cecil textbook of medicine. 20th ed. 1996;931-935 W.B. Saunders Company, Philadelphia.
3. Oltra A.M., Carbonell F., Tormos C., Iradi A., Saez G.T. Antioxidant enzyme activities and the production of MDA and 8-oxo-dG in chronic lymphocytic leukemia. Free Radic. Biol. Med. 30:2001;1286-1292.
4. Halliwell B., Gutteridge J.M.C. Protection against oxidants in biological systems: the superoxide theory of oxygen toxicity. Free radicals in Biology and Medicine. 1989;86-179 Clarendon Press, Oxford.
5. Mantovani G., Macciò A., Madeddu C.et al. Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status. Int. J. Cancer. 98:2002;84-91.
6. Mantovani G., Macciò A., Lai P., Massa E., Ghiani M., Santona M.C. Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate. Semin. Oncol. 25(Suppl. 6):1998;45-52.
7. Weijl N.I., Cleton F.J., Osanto S. Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treat. Rev. 23:1997;209-240.
8. Trush M.A., Kensler T.W. An overview of the relationship between oxidative stress and chemical carcinogenesis. Free Radic. Biol. Med. 10:1991;201-209.
9. Marnett L. Peroxyl free radicals: potential mediators of tumor initiation and promotion. Carcinogenesis. 8:1987;1365-1373.
10. Yagi K. Increased lipid peroxides initiate atherogenesis. BioEssays. 1:1984;58-60.
11. Taysi S., Uslu C., Akcay F., Sütbeyaz M.Y. Concentrations of malondialdehyde and nitric oxide in plasma of patients with advanced laryngeal cancer. Surg. Today. 33:2003;64-65.
12. Taysi S., Polat F., Gul M., Sari R.A., Bakan E. Lipid peroxidation, some extracellular antioxidants and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol. Int. 21:2002;200-204.
13. Taysi S., Gul M., Sari R.A., Akcay F., Bakan N. Oxidant/antioxidant status in serum of patients with systemic lupus erythematosus. Clin. Chem. Lab. Med. 40:2002;684-688.
14. Taysi S., Kocer I., Memisogullari R., Kiziltunc A. Serum oxidant/antioxidant status in patients with Behcet's disease. Ann. Clin. Lab. Sci. 32:2002;377-382.
15. Gul M., Kutay F.Z., Temocin S., Hänninen O. Cellular and clinical implications of glutathione. Indian J. Exp. Biol. 38:2000;625-634.
16. Michiels C., Raes M., Toussaint O., Remacle J. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic. Biol. Med. 17:1994;235-248.
17. Polat F.M., Taysi S., Gul M., Cikman O., Yilmaz I., Bakan E.et al. Oxidant/antioxidant status in blood of patients with malignant breast tumor and benign breast disease. Cell Biochem. Funct. 20:2002;327-331.
18. Xu W., Liu L.Z., Loizodou M., Ahmed M., Charles I.G. The role of nitric oxide in cancer. Cell Res. 12:2002;311-320.
19. Jenkins D.C., Charles I.G., Thomsen L.L., Moss D.W., Holmes L.S., Baylis S.A.et al. Role of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. 92:1995;4392-4396.
20. Mahesh S.J., Julie L.P., Jack R.L.J.R. Cellular antioxidant and pro-oxidant actions of nitric oxide. Free Radic. Biol. Med. 27:1999;1357-1366.
21. Ohshima H., Bartsch H. Chronic infections and inflammatory process as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res. 305:1994;253-264.
22. Rai K.R., Stawitsky A., Cronkite E.P., Chanana A.D., Levy R.N., Pasternack B.S. Clinical staging of chronic lymphocytic leukemia. Blood. 46:1975;941-945.
23. Jain S.K., McVie R., Duett J., Herbst J.J. Erythrocyte membrane lipid peroxidation and glycocylated hemoglobin in diabetes. Diabetes. 38:1989;1539-1543.
24. Sun Y., Oberley L.W., Li Y. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 34:1988;497-500.
25. Paglia D.E., Valentina W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70:1967;158-169.
26. Pinto R.E., Bartley W. The effect of age and sex on glutathione reductase and glutathione peroxidase activities and on aerobic glutathione oxidation in rat liver homogenates. Biochem. J. 112:1969;109-115.
27. Fairbanks V.F., Klee G.G. Biochemical aspects of hematology. Burtis C.A., Ashwood E.R. Tietz Textbook of Clinical Chemistry. 1999;1990-2106 Saunders, Philadelphia.
28. Moshage H., Kok B., Huizenga J.R.et al. Nitrite and nitrate determinations in plasma: a critical evaluation. Clin. Chem. 41:1995;892-896.
29. Bories P.N., Bories C. Nitrate determination in biological fluids by an enzymatic one step assay with nitrate reductase. Clin. Chem. 41:1995;904-907.
30. Jaruga P., Zastawny T.H., Skokowski J.et al. Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer. FEBS Lett. 14:1994;59-64.
31. Sun Y., Oberley L.W. Redox regulation of transcriptional activators. Free Radic. Biol. Med. 21:1996;335-348.
32. Blackburn R.V., Spitz D.R., Liu X.et al. Metabolic oxidative stress activates signal transduction and gene expression during glucose deprivation in human tumor cells. Free Radic. Biol. Med. 26:1999;419-430.
33. Toyokuni S., Okamoto K., Yodoi J., Hiai H. Persistent oxidative stress in cancer. FEBS Lett. 16:1995;3581-3583.
34. Meyer T.E., Liang H.Q., Buckley A.R.et al. Changes in glutathione redox cycling and oxidative stress response in the malignant progression of NB2 lymphoma cells. Int. J. Cancer. 3:1998;55-63.
35. Navarro J., Obrador E., Carretero J.et al. Changes in glutathione status and the antioxidant system in blood and in cancer cells associate with tumor growth in vivo. Free Radic. Biol. Med. 26:1999;410-418.
36. 2 by human tumor cells. Cancer Res. 51:1991;794-798.
37. Seven A., Civelek S., İnci E.et al. Evaluation of oxidative stress parameters in blood of patients with laryngeal carcinoma. Clin. Biochem. 32:1999;369-373.
38. Marnett L.J. Lipid peroxidation-DNA damage by malondialdehyde. Mutat. Res. 424:1999;83-95.
39. Ghalaut V.S., Ghalaut P.S., Singh S. Lipid peroxidation in leukemia. JAPA. 47:1999;403-405.
40. Huang Y.L., Sheu J.Y., Lin T.H. Association between oxidative stress and changes of trace elements in patients with breast cancer. Clin. Biochem. 32:1999;131-136.
41. Seven A., Civelek S., İnci E.et al. Evaluation of oxidative stress parameters in blood of patients with laryngeal carcinoma. Clin. Biochem. 32:1999;369-373.
42. Samir M., El kholy N.M. Thiobarbituric acid reactive substances in patients with laryngeal cancer. Clin. Otolaryngol. 24:1999;232-234.
43. Arivazhagan S., Kavitha K., Nagini S. Erythrocyte lipid peroxidation and antioxidants in gastric cancer patients. Cell Biochem. Funct. 15:1997;15-18.
44. Bakan E., Taysi S., Polat M.F., Dalga S., Umudum Z., Bakan N.et al. Nitric oxide concentrations and lipid peroxidation in plasma of patients with gastric cancer. Jpn. J. Clin. Oncol. 32:2002;162-166.
45. Alagol H., Erdem E., Sancak B., Turkmen G., Camlibel M., Bugdayci G. Nitric oxide biosynthesis and malondialdehyde concentrations in advanced breast cancer. Aust. N.Z. J. Surg. 69:1999;647-650.
46. Seven A., Erbil Y., Seven R., Inci F., Gulyasar T., Barutcu B.et al. Breast cancer and benign breast disease patients evaluated in relation to oxidative stress. Cancer Biochem. Biophys. 16:1998;333-345.
47. Gerber M., Astre C., Segala C., Saintot M., Scali J., Simony-Lafontaine J.et al. Oxidant-antioxidant status alterations in cancer patients: relationship to tumor progression. J. Nutr. 126(4 Suppl):1996 (April);1201S-1207S.
48. Silber R., Farber C.M., Papadopoulos E., Nevrla D., Liebes L., Bruck M. et al. Glutathione depletion in chronic lymphocytic leukemia B lymphocytes. Blood. 80:1992 (Oct. 15);2038-2043.
49. Farber C.M., Kanganis D.N., Liebes L.F., Silber R. Antioxidant enzymes in lymphocytes from normal subjects and patients with chronic lymphocytic leukemia: increased glutathione peroxidase activity in CLL B lymphocytes. Br. J. Haematol. 72:1989;32-35.
50. Ferraris A.M., Rolfo M., Mangerini R., Gaetani G.F. Increased glutathione in chronic lymphocytic leukemia lymphocytes. Am. J. Hematol. 47:1994;237-238.
51. Beutler E., Plasma T. Gelbart glutathione in health and in patients with malignant disease. J. Lab. Clin. Med. 105:1985;581-584.
52. Gerber M., Astre C., Segala C., Saintot M., Scali J., Simony-Lafontaine J.et al. Tumor progression and oxidant-antioxidant status. Cancer Lett. 114:1997;211-214.
53. Goto T., Haruma K., Kitadai Y., Ito M., Yoshihara M., Sumii K.et al. Enhanced expression of inducible nitric oxide synthase and nitrotyrosine in gastric mucosa of gastric cancer patients. Clin. Cancer Res. 5:1999;1411-1415.
54. Haklar G., Sayin-Özveri E., Yüksel M., Aktan A.Ö., Yalçin A.S. Different kinds of reactive oxygen and nitrogen species were detected in colon and breast tumors. Cancer Lett. 165:2001;219-224.
55. Szaleczky E., Pronai L., Nakazawa H., Tulassay Z. Evidence of in vivo peroxynitrite formation in patients with colourectal carcinoma, higher plasma nitrite/nitrate concentrations, and lower protection against oxygen free radicals. J. Clin. Gastroenterol. 30:2000;47-51.
56. Eijan A.M., Piccardo I., Riveros M.D., Sandes E.O., Porcella H., Jasnis M.A.et al. Nitric oxide in patients with transitional bladder cancer. J. Surg. Oncol. 81:2002;203-208.
57. Maeda H., Akaike T. Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry (Mosc.). 63:1998;854-865.
58. Taysi S., Koc M., Buyukokuroglu M.E., Altinkaynak K., Sahin Y.N. Melatonin reduces lipid peroxidation and nitric oxide during irradiation-induced oxidative injury in the rat liver. J. Pineal Res. 34:2003;173-177.